Status:
UNKNOWN
Reference Values of Circulating Endothelial Progenitor Cells
Lead Sponsor:
Hopital Jean Minjoz
Conditions:
Aortic Aneurysm
Eligibility:
All Genders
18-65 years
Brief Summary
Circulating endothelial progenitor cells CD34+144+CD14- et CD34+VEGF-R2+CD14- have been shown to be inversely correlated to aortic aneurysm size. However reference values have not yet been determined....
Detailed Description
At the time of blood donation, 10mL of blood will be used to calculate the concentration of circulating endothelial progenitor cells CD34+144+CD14- et CD34+VEGF-R2+CD14- , and the ratio of circulating...
Eligibility Criteria
Inclusion
- Blood donors
Exclusion
- age over 65
- Arterial hypertension (treated or not)
- Vascular disease
- smoker or former smoker who stopped smoking for less than a year
Key Trial Info
Start Date :
October 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2014
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT01918969
Start Date
October 1 2013
End Date
March 1 2014
Last Update
August 8 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Besançon
Besançon, France, 25030